Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study

被引:12
|
作者
Muyoyeta, Monde [1 ]
Kerkhoff, Andrew D. [2 ,3 ]
Chilukutu, Lophina [1 ]
Moreau, Emmanuel [4 ]
Schumacher, Samuel G. [4 ]
Ruhwald, Morten [4 ]
机构
[1] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[2] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[3] Univ Calif San Francisco, Ctr Trauma, Div HIV Infect Dis & Global Med, San Francisco, CA 94117 USA
[4] Fdn Innovat New Diagnost FIND, Geneva, Switzerland
关键词
MYCOBACTERIUM-TUBERCULOSIS; XPERT MTB/RIF;
D O I
10.1183/13993003.03999-2020
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM ("FujiLAM")) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia. Methods Adult (> 18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM. Results 151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59-89%) and 92% (95% CI 86-96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43-95%) compared with 75% (95% CI 51-91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60-98%) compared with 68% (95% CI 43-87%) among patients with smear-negative, confirmed pulmonary TB. Conclusions FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study
    Broger, Tobias
    Sossen, Bianca
    du Toit, Elloise
    Kerkhoff, Andrew D.
    Schutz, Charlotte
    Reipold, Elena Ivanova
    Ward, Amy
    Barr, David A.
    Mace, Aurelien
    Trollip, Andre
    Burton, Rosie
    Ongarello, Stefano
    Pinter, Abraham
    Lowary, Todd L.
    Boehme, Catharina
    Nicol, Mark P.
    Meintjes, Graeme
    Denkinger, Claudia M.
    LANCET INFECTIOUS DISEASES, 2019, 19 (08): : 852 - 861
  • [2] Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated Tuberculosis
    Lawn, Stephen D.
    Kerkhoff, Andrew D.
    Nicol, Mark P.
    Meintjes, Graeme
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (04) : E144 - E146
  • [3] Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
    Broger, Tobias
    Nicol, Mark P.
    Szekely, Rita
    Bjerrum, Stephanie
    Sossen, Bianca
    Schutz, Charlotte
    Opintan, Japheth A.
    Johansen, Isik S.
    Mitarai, Satoshi
    Chikamatsu, Kinuyo
    Kerkhoff, Andrew D.
    Mace, Aurelien
    Ongarello, Stefano
    Meintjes, Graeme
    Denkinger, Claudia M.
    Schumacher, Samuel G.
    PLOS MEDICINE, 2020, 17 (05)
  • [4] Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis
    Lawn, Stephen D.
    Kerkhoff, Andrew D.
    Vogt, Monica
    Wood, Robin
    AIDS, 2012, 26 (13) : 1635 - 1643
  • [5] Utilization of point-of-care tests among general practitioners, a cross-sectional study
    Ricarda Oehme
    Angelika Sabine Sandholzer-Yilmaz
    Marcus Heise
    Thomas Frese
    Thomas Fankhaenel
    BMC Primary Care, 23
  • [6] Utilization of point-of-care tests among general practitioners, a cross-sectional study
    Oehme, Ricarda
    Sandholzer-Yilmaz, Angelika Sabine
    Heise, Marcus
    Frese, Thomas
    Fankhaenel, Thomas
    BMC PRIMARY CARE, 2022, 23 (01):
  • [7] Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study
    Nkereuwem, Esin
    Togun, Toyin
    Gomez, Marie P.
    Szekely, Rita
    Mace, Aurelien
    Jobe, Dawda
    Schumacher, Samuel G.
    Kampmann, Beate
    Denkinger, Claudia M.
    LANCET INFECTIOUS DISEASES, 2021, 21 (03): : 376 - 384
  • [8] Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study
    Reeve, Byron W. P.
    Ndlangalavu, Gcobisa
    Mishra, Hridesh
    Palmer, Zaida
    Tshivhula, Happy
    Rockman, Loren
    Naidoo, Selisha
    Mbu, Desiree L.
    Naidoo, Charissa C.
    Derendinger, Brigitta
    Walzl, Gerhard
    Malherbe, Stephanus
    van Helden, Paul D.
    Semitala, Fred C.
    Yoon, Christina
    Gupta, Rishi K.
    Noursadeghi, Mahdad
    Warren, Robin M.
    Theron, Grant
    LANCET GLOBAL HEALTH, 2024, 12 (05): : e793 - e803
  • [9] Evaluation of a point-of-care immunochromatographic assay for enteric fever in Dhaka, Bangladesh: a prospective diagnostic accuracy study
    Munira, Sira J.
    Islam, Nahidul
    Tprithe, Nowshin
    Sarkar, Anik
    Esfandiari, Javan
    Gunasekera, Dhammika
    Islam, Shuborno
    Akter, Tanjila
    Garrett, Denise
    Saha, Samir K.
    Andrews, Jason R.
    Saha, Senjuti
    Charles, Richelle C.
    LANCET MICROBE, 2025, 6 (03):
  • [10] Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study
    Drain, Paul K.
    Losina, Elena
    Coleman, Sharon M.
    Giddy, Janet
    Ross, Douglas
    Katz, Jeffrey N.
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Bassett, Ingrid V.
    BMC INFECTIOUS DISEASES, 2014, 14